Okay kiddo, here's what the article is about in simple words: There are three health care stocks that might lose value soon. They are Atrion, Harpoon Therapeutics, and another one. People who buy and sell these stocks look at something called RSI to see if they should buy or sell them. Right now, these three stocks have a high RSI, which means some people might want to sell them soon because they think the price will go down. Read from source...

1. The article is misleading and sensationalist by implying that the stocks may plunge in January without providing any evidence or analysis to support this claim. It relies on a vague and subjective indicator, such as RSI, which can be influenced by many factors and does not guarantee future performance.
2. The article is selectively presenting information by focusing only on the negative aspects of these stocks, while ignoring any positive developments or potential opportunities for growth. It also uses a short-term perspective, which may not reflect the long-term prospects of these companies in the health care sector.
3. The article is using emotional language and tone, such as "warning", "flashing", "plunge", which may trigger fear or anxiety among readers and pressure them to make hasty decisions based on incomplete information. It also seems to be targeting a non-expert audience who may not understand the nuances of stock market analysis or the limitations of RSI as a metric.
4. The article is showing signs of confirmation bias, which is the tendency to seek out and interpret information that confirms one's existing beliefs or expectations. For example, it cites Oppenheimer analyst Hartaj Singh who initiated coverage on Harpoon Therapeutics with an Outperform rating, but does not mention any other opinions or perspectives from different sources or experts.
5. The article is lacking in credibility and authority, as it does not provide any credentials or qualifications of the author, Avi Kapoor, who may be influenced by personal bias or agenda. It also does not disclose any potential conflicts of interest or affiliations with other parties that may benefit from this article's content or sentiment.